The information provided on this page is for reference only. Please refer to the latest information published by the partner company.
HealthBaby Biotech (Hong Kong) Co., Ltd (HealthBaby) established since 2006 and is a subsidiary of SGX-listed company with solid foothold in Asia covering Singapore, China, Hong Kong, Macau, India, Indonesia, Philippines, Malaysia and Thailand.
We are the first cord blood bank located in Hong Kong Science & Technology Park. HealthBaby adopted the most advanced technologies, facilities and experiences from U.S.A. to the market. We attained the most local and international accreditations (incl. FACT, CAP and AABB), as well as awards from corporations and government. In 2011, HealthBaby launched the brand new laboratory and office (occupying >10,000 sq. ft.) and becomes the largest Hong Kong cord blood bank.
The Group has released 45 cord blood units for the treatment of various health conditions. Apart from providing the most advanced cord blood storage, we are the first to offer cord tissue storage in Hong Kong stem cell industry(1). Moreover, HealthBaby ‘s exlcusive cord technology has attained H.K. patent.
As the No.1 cord blood bank in Hong Kong, from 2009 onwards, we have been entrusted by most parents for 10 consecutive years (2) & the Group shares more than 90% of the cord blood banking market(3). In 2010, HealthBaby was recommended by most private O&G doctors in Hong Kong (4). From 2011-2016, HealthBaby has been awarded Reader’s Digest Trusted Brand – Platinum Award for 6 consecutive years.
(1) Introduction to the Cord Tissue Market and Cord Tissue-Derived Mesenchymal Stem Cells (CT-MSCs)", BIOINFORMANT, Jun 2015
(2) Ipsos Healthcare 2009 - 2018 Cord Blood Bank Survey
(3) Ipsos Healthcare 2018 Cord Blood Bank Survey
(4) IMS-2010 Cord Blood Bank Market Research in Hong Kong